Quarterly Consolidated Balance Sheet

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7586092

Concept As at
2022-09-30
As at
2022-03-31
Quarterly consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
17,224,000,000 JPY
12,103,000,000 JPY
Securities
JPY
5,000,000,000 JPY
Merchandise and finished goods
9,865,000,000 JPY
10,016,000,000 JPY
Work in process
512,000,000 JPY
457,000,000 JPY
Raw materials and supplies
5,779,000,000 JPY
4,587,000,000 JPY
Other
3,112,000,000 JPY
2,911,000,000 JPY
Allowance for doubtful accounts
JPY
0 JPY
Current assets
52,852,000,000 JPY
49,557,000,000 JPY
Non-current assets
Property, plant and equipment
10,798,000,000 JPY
10,936,000,000 JPY
Property, plant and equipment
Intangible assets
Intangible assets
5,192,000,000 JPY
6,183,000,000 JPY
Investments and other assets
17,383,000,000 JPY
16,620,000,000 JPY
Investments and other assets
Investment securities
13,274,000,000 JPY
12,223,000,000 JPY
Other
4,126,000,000 JPY
4,414,000,000 JPY
Allowance for doubtful accounts
-17,000,000 JPY
-17,000,000 JPY
Non-current assets
33,374,000,000 JPY
33,739,000,000 JPY
Assets
86,227,000,000 JPY
83,297,000,000 JPY
Liabilities
Current liabilities
Notes and accounts payable - trade
4,299,000,000 JPY
3,118,000,000 JPY
Short-term borrowings
2,848,000,000 JPY
1,723,000,000 JPY
Other
7,228,000,000 JPY
6,257,000,000 JPY
Current liabilities
17,995,000,000 JPY
16,011,000,000 JPY
Non-current liabilities
Long-term borrowings
10,049,000,000 JPY
12,323,000,000 JPY
Retirement benefit liability
5,849,000,000 JPY
5,730,000,000 JPY
Other
330,000,000 JPY
338,000,000 JPY
Non-current liabilities
16,229,000,000 JPY
18,393,000,000 JPY
Liabilities
34,224,000,000 JPY
34,404,000,000 JPY
Net assets
Shareholders' equity
Share capital
1,197,000,000 JPY
1,197,000,000 JPY
Capital surplus
1,847,000,000 JPY
1,867,000,000 JPY
Retained earnings
47,954,000,000 JPY
45,833,000,000 JPY
Treasury shares
-3,375,000,000 JPY
-3,479,000,000 JPY
Shareholders' equity
47,624,000,000 JPY
45,419,000,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
3,739,000,000 JPY
3,231,000,000 JPY
Foreign currency translation adjustment
547,000,000 JPY
164,000,000 JPY
Remeasurements of defined benefit plans
91,000,000 JPY
77,000,000 JPY
Valuation and translation adjustments
4,378,000,000 JPY
3,473,000,000 JPY
Net assets
52,002,000,000 JPY
48,892,000,000 JPY
Liabilities and net assets
86,227,000,000 JPY
83,297,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.